These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Fulminant metoclopramide induced neuroleptic malignant syndrome rapidly responsive to intravenous dantrolene. Henderson A; Longdon P Aust N Z J Med; 1991 Oct; 21(5):742-3. PubMed ID: 1759924 [TBL] [Abstract][Full Text] [Related]
5. Neuroleptic malignant syndrome associated with metoclopramide in a burn patient. Nachreiner R; Balledux J; Zieger M; Viegas O; Sood R J Burn Care Res; 2006; 27(2):237-41. PubMed ID: 16566575 [TBL] [Abstract][Full Text] [Related]
6. Neuroleptic malignant syndrome induced by droperidol. So PC Hong Kong Med J; 2001 Mar; 7(1):101-3. PubMed ID: 11406684 [TBL] [Abstract][Full Text] [Related]
7. Neuroleptic malignant syndrome associated with metoclopramide. Patterson JF South Med J; 1988 May; 81(5):674-5. PubMed ID: 3368821 [TBL] [Abstract][Full Text] [Related]
14. Neuroleptic Malignant Syndrome Secondary to Metoclopramide Use in an Elderly Gastroenterologic Surgery Patient. Breeden R; Ford H; Chrisman C; Mascioli C Gastroenterol Nurs; 2017; 40(2):93-100. PubMed ID: 28362659 [TBL] [Abstract][Full Text] [Related]
15. Neuroleptic malignant syndrome in a child treated with metoclopramide for chemotherapy-related nausea. Brower RD; Dreyer CF; Kent TA J Child Neurol; 1989 Jul; 4(3):230-2. PubMed ID: 2768791 [No Abstract] [Full Text] [Related]